Company Filing History:
Years Active: 2023
Title: David Michael Hyman: Innovator in Cancer Treatment
Introduction
David Michael Hyman is a notable inventor based in Westport, CT (US). He has made significant contributions to the field of cancer treatment through his innovative work. His dedication to research and development has led to the creation of valuable pharmaceutical compounds.
Latest Patents
Hyman holds a patent for KRas G12C inhibitors. This invention provides compounds that are designed to treat patients with cancer. The patent details compounds of a specific formula, including pharmaceutically acceptable salts and methods for their use in cancer treatment.
Career Highlights
David Michael Hyman is associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to focus on developing groundbreaking treatments that can improve patient outcomes in oncology.
Collaborations
Hyman has collaborated with notable colleagues, including Serge Louis Boulet and Kevin Charles Fortner. These partnerships have fostered an environment of innovation and have contributed to the advancement of cancer therapies.
Conclusion
David Michael Hyman's contributions to cancer treatment through his patent for KRas G12C inhibitors exemplify his commitment to improving healthcare. His work continues to inspire advancements in the pharmaceutical industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.